Yang C, Compans R W
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
J Virol. 1997 Nov;71(11):8490-6. doi: 10.1128/JVI.71.11.8490-8496.1997.
In previous studies, the C-terminal R peptide of the murine leukemia virus (MuLV) Env protein was shown to be a potent inhibitor of viral fusion activity. In the present study, we investigated the molecular determinants in the MuLV Env protein cytoplasmic tail which are important for the fusion inhibition activity of the R peptide. We constructed a series of mutant MuLV env genes which express Env proteins with serial truncations, internal deletions, or amino acid substitutions in the cytoplasmic tail. To analyze their cell fusion activity, we employed a quantitative fusion assay. We found that truncations of up to 7 amino acids from the C terminus of the cytoplasmic tail had no detectable effect on the lack of fusion activity of the full-length Env protein; however, further truncations resulted in a progressive increase in cell fusion activity. Studies of mutant proteins with amino acid substitutions in the cytoplasmic tail showed that Leu-627 plays an important role in fusion inhibition by the R peptide, while most of the other amino acids in the R peptide were not essential for fusion inhibition. Studies of mutant proteins with internal deletions upstream of the cleavage site in the cytoplasmic tail showed that this region is also involved in fusion inhibition by the R peptide, although only to a limited extent. The results are consistent with a model in which the MuLV R peptide exhibits its fusion inhibition activity through interaction with a cellular factor(s).
在先前的研究中,鼠白血病病毒(MuLV)Env蛋白的C末端R肽被证明是病毒融合活性的有效抑制剂。在本研究中,我们调查了MuLV Env蛋白胞质尾部中对于R肽融合抑制活性很重要的分子决定因素。我们构建了一系列突变的MuLV env基因,这些基因表达在胞质尾部具有连续截短、内部缺失或氨基酸替换的Env蛋白。为了分析它们的细胞融合活性,我们采用了定量融合测定法。我们发现,从胞质尾部C末端截短多达7个氨基酸对全长Env蛋白缺乏融合活性没有可检测到的影响;然而,进一步截短会导致细胞融合活性逐渐增加。对胞质尾部具有氨基酸替换的突变蛋白的研究表明,Leu-627在R肽的融合抑制中起重要作用,而R肽中的大多数其他氨基酸对于融合抑制并非必需。对胞质尾部切割位点上游具有内部缺失的突变蛋白的研究表明,该区域也参与R肽的融合抑制,尽管程度有限。这些结果与一个模型一致,即MuLV R肽通过与一种细胞因子相互作用来发挥其融合抑制活性。